Clinical Trials Logo

Clinical Trial Summary

Patients undergoing gynecological surgery are at high risk of developing postoperative sleep disorders. Intraoperative opioid use is detrimental to the patient's postoperative recovery of gastrointestinal function. Esketamine has sedative, hypnotic, analgesic, inflammatory response suppression, and antidepressant effects. Its hypnotic mechanism may be related to its rapid blockade of NMDA receptors and hyperpolarization-activated cyclic nucleotide-gated cation channels. Also can reduce the application of perioperative opioids, which in turn promotes the recovery of gastrointestinal function in patients after surgery.


Clinical Trial Description

n/a


Study Design


NCT number NCT05715671
Study type Interventional
Source Yangzhou University
Contact
Status Completed
Phase N/A
Start date March 25, 2023
Completion date December 31, 2023